Literature DB >> 20192475

Review on heavy ion radiotherapy facilities and related ion sources (invited).

A Kitagawa1, T Fujita, M Muramatsu, S Biri, A G Drentje.   

Abstract

Heavy ion radiotherapy awakens worldwide interest recently. The clinical results obtained by the Heavy Ion Medical Accelerator in Chiba at the National Institute of Radiological Sciences in Japan have clearly demonstrated the advantages of carbon ion radiotherapy. Presently, there are four facilities for heavy ion radiotherapy in operation, and several new facilities are under construction or being planned. The most common requests for ion sources are a long lifetime and good stability and reproducibility. Sufficient intensity has been achieved by electron cyclotron resonance ion sources at the present facilities.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20192475     DOI: 10.1063/1.3268510

Source DB:  PubMed          Journal:  Rev Sci Instrum        ISSN: 0034-6748            Impact factor:   1.523


  4 in total

1.  The role of gap junction communication and oxidative stress in the propagation of toxic effects among high-dose α-particle-irradiated human cells.

Authors:  Narongchai Autsavapromporn; Sonia M de Toledo; John B Little; Jean-Paul Jay-Gerin; Andrew L Harris; Edouard I Azzam
Journal:  Radiat Res       Date:  2011-01-10       Impact factor: 2.841

2.  Proton Therapy for Mandibula Plate Phantom.

Authors:  Güler Burcu Senirkentli; Fatih Ekinci; Erkan Bostanci; Mehmet Serdar Güzel; Özlem Dağli; Ahmed M Karim; Alok Mishra
Journal:  Healthcare (Basel)       Date:  2021-02-04

3.  Systematic analysis of RBE and related quantities using a database of cell survival experiments with ion beam irradiation.

Authors:  Thomas Friedrich; Uwe Scholz; Thilo Elsässer; Marco Durante; Michael Scholz
Journal:  J Radiat Res       Date:  2012-12-23       Impact factor: 2.724

4.  A step towards international prospective trials in carbon ion radiotherapy: investigation of factors influencing dose distribution in the facilities in operation based on a case of skull base chordoma.

Authors:  G Vogin; A Wambersie; M Koto; T Ohno; M Uhl; P Fossati; J Balosso
Journal:  Radiat Oncol       Date:  2019-02-01       Impact factor: 3.481

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.